Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects

ClinicalTrials.gov ID: NCT00765856

Public ClinicalTrials.gov record NCT00765856. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 7:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.

Study identification

NCT ID
NCT00765856
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Endo USA Inc., a Keenova Therapeutics Company
Industry
Enrollment
27 participants

Conditions and interventions

Conditions

Interventions

  • Oxymorphone ER Drug

Drug

Eligibility (public fields only)

Age range
6 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 16, 2008
Primary completion
Feb 21, 2010
Completion
Feb 21, 2010
Last update posted
Dec 15, 2020

2008 – 2010

United States locations

U.S. sites
13
U.S. states
11
U.S. cities
13
Facility City State ZIP Site status
Arkansas Childrens's Hospital-Division of Pediatric Anestesia and Pain Medicine Little Rock Arkansas 72202
Stanford University School of Medicine Stanford California 94305
The Children's Hospital Aurora Colorado 80045
Connecticut Children's Medical Center Hartford Connecticut 06106
Children's National Medical Center Washington D.C. District of Columbia 20010
Florida Institute of Medical Research Jacksonville Florida 32257
Tukoi Clinical Research Miami Florida 34104
St. Joseph's Children's Hospital of Tampa Tampa Florida 33618
Taylor Research, LLC Marietta Georgia 30060
Rehabilitation Associates of Indiana Indianapolis Indiana 46250
University of Louisville Reserach Foundation, Inc. Louisville Kentucky 40202
The Center for Clinical Research Winston-Salem North Carolina 27103
Hershey Medical Center Hershey Pennsylvania 17112

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00765856, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 15, 2020 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00765856 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →